WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 526854

CAS#: 1254977-87-1

Description: JNJ-42153605 is a potent and selective mGlu2 receptor PAM with an acceptable pharmacokinetic profile in rodent and nonrodent species. JNJ-42153605 showed centrally mediated in vivo effectivity in models sensitive to mGlu2 receptor modulation such as sleep−wake electroencephalogram (sw-EEG) in rats,34 showing suppressed REM sleep during the first 4 h after oral administration of a 3 mg/kg dose.

Price and Availability

Size Price Shipping out time Quantity
100mg USD 950 2 Weeks
200mg USD 1650 2 Weeks
500mg USD 2150 2 Weeks
1g USD 3250 2 Weeks
2g USD 4350 2 Weeks
5g USD 7250 2 Weeks
Inquire bulk and customized quantity

Pricing updated 2021-01-24. Prices are subject to change without notice.

JNJ-42153605, purity > 98%, is in stock. Current shipping out time is about 2 weeks after order is received. CoA, QC data and MSDS documents are available in one week after order is received.

Chemical Structure


Theoretical Analysis

MedKoo Cat#: 526854
Name: JNJ-42153605
CAS#: 1254977-87-1
Chemical Formula: C22H23F3N4
Exact Mass: 400.1875
Molecular Weight: 400.4492
Elemental Analysis: C, 65.99; H, 5.79; F, 14.23; N, 13.99

Synonym: JNJ-42153605; JNJ 42153605; JNJ42153605.

IUPAC/Chemical Name: 3-(Cyclopropylmethyl)-7-(4-phenyl-1-piperidinyl)-8-(trifluoromethyl)[1,2,4]triazolo[4,3-a]pyridine


InChi Code: InChI=1S/C22H23F3N4/c23-22(24,25)20-18(10-13-29-19(14-15-6-7-15)26-27-21(20)29)28-11-8-17(9-12-28)16-4-2-1-3-5-16/h1-5,10,13,15,17H,6-9,11-12,14H2


Technical Data

Solid powder

>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Soluble in DMSO

Shelf Life:
>2 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code:


1: Ahnaou A, Lavreysen H, Tresadern G, Cid JM, Drinkenburg WH. mGlu2 Receptor
Agonism, but Not Positive Allosteric Modulation, Elicits Rapid Tolerance towards
Their Primary Efficacy on Sleep Measures in Rats. PLoS One. 2015 Dec
11;10(12):e0144017. doi: 10.1371/journal.pone.0144017. eCollection 2015. PubMed
PMID: 26658273; PubMed Central PMCID: PMC4684355.

2: Lavreysen H, Langlois X, Donck LV, Nuñez JM, Pype S, Lütjens R, Megens A.
Preclinical evaluation of the antipsychotic potential of the mGlu2-positive
allosteric modulator JNJ-40411813. Pharmacol Res Perspect. 2015 Mar;3(2):e00097.
doi: 10.1002/prp2.97. Epub 2015 Jan 30. PubMed PMID: 25692027; PubMed Central
PMCID: PMC4324682.

3: Wyckhuys T, Wyffels L, Langlois X, Schmidt M, Stroobants S, Staelens S. The
[18F]FDG μPET readout of a brain activation model to evaluate the metabotropic
glutamate receptor 2 positive allosteric modulator JNJ-42153605. J Pharmacol Exp
Ther. 2014 Aug;350(2):375-86. doi: 10.1124/jpet.114.213959. Epub 2014 Jun 4.
PubMed PMID: 24898267.

4: Megens AA, Hendrickx HM, Hens KA, Talloen WJ, Lavreysen H. mGlu(2)
receptor-mediated modulation of conditioned avoidance behavior in rats. Eur J
Pharmacol. 2014 Mar 15;727:130-9. doi: 10.1016/j.ejphar.2014.01.044. Epub 2014
Jan 30. PubMed PMID: 24486391.

5: Cid JM, Tresadern G, Vega JA, de Lucas AI, Matesanz E, Iturrino L, Linares ML,
Garcia A, Andrés JI, Macdonald GJ, Oehlrich D, Lavreysen H, Megens A, Ahnaou A,
Drinkenburg W, Mackie C, Pype S, Gallacher D, Trabanco AA. Discovery of
,3-a]pyridine (JNJ-42153605): a positive allosteric modulator of the metabotropic
glutamate 2 receptor. J Med Chem. 2012 Oct 25;55(20):8770-89. doi:
10.1021/jm3010724. Epub 2012 Oct 16. PubMed PMID: 23072213.